Persistent Depressive Disorder Research & Evidence-Based Practice 3 — Questions and Answers
Question 1: According to evidence-based guidelines, what is the recommended minimum duration of antidepressant treatment after achieving remission from PDD?
- At least 2 years due to the chronic nature of the condition (Correct answer)
- 6 months, same as for a single MDD episode
- 3 months for symptom stabilization only
- Indefinite treatment is never recommended
Correct answer: At least 2 years due to the chronic nature of the condition
Due to PDD's chronic nature and high relapse risk, evidence-based guidelines recommend at least 2 years of maintenance pharmacotherapy after achieving remission.
Question 2: Research on the neurobiological underpinnings of PDD has implicated which brain region most consistently in structural neuroimaging studies?
- Hippocampus, with reduced volume compared to healthy controls (Correct answer)
- Amygdala enlargement relative to controls
- Prefrontal cortex hyperactivity at rest
- Cerebellum with reduced gray matter density
Correct answer: Hippocampus, with reduced volume compared to healthy controls
Neuroimaging studies of PDD and related chronic depression consistently find hippocampal volume reduction, likely related to chronic cortisol exposure.
Question 3: A researcher studying treatment-resistant PDD would most likely investigate which augmentation strategy based on current evidence?
- Atypical antipsychotic augmentation (e.g., quetiapine or aripiprazole) (Correct answer)
- Adding a second SSRI from the same drug class
- High-dose benzodiazepine augmentation
- Antibiotic augmentation targeting gut microbiome exclusively
Correct answer: Atypical antipsychotic augmentation (e.g., quetiapine or aripiprazole)
Evidence supports atypical antipsychotic augmentation for treatment-resistant depression, with quetiapine and aripiprazole having the strongest evidence base.
Question 4: What does research show about the relationship between childhood adversity and PDD development?
- Childhood adversity significantly increases PDD risk and is associated with earlier onset and greater severity (Correct answer)
- Childhood adversity has no independent effect on PDD risk after controlling for genetics
- Only physical abuse (not neglect or emotional abuse) predicts PDD
- Childhood adversity predicts MDD but not specifically PDD
Correct answer: Childhood adversity significantly increases PDD risk and is associated with earlier onset and greater severity
Research demonstrates that childhood adversity is a robust predictor of PDD, associated with earlier onset, greater severity, and poorer treatment outcomes through both psychological and biological pathways.
Question 5: In clinical trials evaluating mindfulness-based cognitive therapy (MBCT) for PDD, what is the primary evidence-supported use?
- Relapse prevention in recurrent depression, with emerging evidence for chronic depression (Correct answer)
- Acute symptom reduction superior to antidepressants
- First-line monotherapy for PDD without medication
- Exclusively for patients who refuse pharmacotherapy
Correct answer: Relapse prevention in recurrent depression, with emerging evidence for chronic depression
MBCT has strong evidence for relapse prevention in recurrent depression, with growing evidence supporting its use as an adjunct for chronic depression including PDD.
Question 6: Research on interpersonal psychotherapy (IPT) adaptations for PDD suggests which modification is most important?
- Extending treatment duration and addressing chronic interpersonal patterns rather than acute grief or role transitions (Correct answer)
- Shortening treatment to 8 sessions for better adherence
- Focusing exclusively on medication compliance rather than relationships
- Removing the grief work component entirely
Correct answer: Extending treatment duration and addressing chronic interpersonal patterns rather than acute grief or role transitions
IPT for PDD requires extended treatment and a focus on chronic interpersonal patterns, as the standard 16-session format for acute MDD is insufficient for the chronically dysthymic patient.
Question 7: A study examining the prevalence of PDD in primary care settings would most likely find what percentage of patients meet criteria?
- Approximately 3-6% of primary care patients (Correct answer)
- Less than 0.5% of primary care patients
- Greater than 20% of primary care patients
- Exactly the same prevalence as in the general population (1.5%)
Correct answer: Approximately 3-6% of primary care patients
PDD is disproportionately represented in primary care settings, with studies estimating 3-6% prevalence, higher than community samples due to help-seeking behavior.
Persistent Depressive Disorder Research & Evidence-Based Practice 3
According to evidence-based guidelines, what is the recommended minimum duration of antidepressant treatment after achieving remission from PDD?